BACKGROUND AND PURPOSE: Inflammation of an atherosclerotic plaque is a well-known risk factor in the development of ischemic stroke and myocardial infarction. MR imaging is capable of characterizing inflammation by assessing plaque enhancement in both extracranial carotid arteries and coronary arteries. Our goal was to determine whether enhancing intracranial atherosclerotic plaque was present in the vessel supplying the territory of infarction by using high-resolution vessel wall MR imaging. MATERIALS AND METHODS: High-resolution vessel wall 3T MR imaging studies performed in 29 patients with ischemic stroke and intracranial vascular stenoses were reviewed for presence and strength of plaque enhancement. RESULTS: Sixteen patients were studied during the acute phase (<4 weeks from acute stroke), 5 patients in the subacute phase (4-12 weeks), and 8 patients in the chronic phase (>12 weeks) of the ischemic injury. In all of the acute phase patients, atherosclerotic plaque in the vessel supplying the stroke territory demonstrated strong enhancement. There was a trend of decreasing enhancement as the time of imaging relative to the ischemic event increased. CONCLUSIONS: Strong pathologic enhancement of intracranial atherosclerotic plaque was seen in all patients imaged within 4 weeks of ischemic stroke in the vessel supplying the stroke territory. The strength and presence of enhancement of the atherosclerotic plaque decreased with increasing time after the ischemic event. These findings suggest a relationship between enhancing intracranial atherosclerotic plaque and acute ischemic stroke.
BACKGROUND AND PURPOSE:Inflammation of an atherosclerotic plaque is a well-known risk factor in the development of ischemic stroke and myocardial infarction. MR imaging is capable of characterizing inflammation by assessing plaque enhancement in both extracranial carotid arteries and coronary arteries. Our goal was to determine whether enhancing intracranial atherosclerotic plaque was present in the vessel supplying the territory of infarction by using high-resolution vessel wall MR imaging. MATERIALS AND METHODS: High-resolution vessel wall 3T MR imaging studies performed in 29 patients with ischemic stroke and intracranial vascular stenoses were reviewed for presence and strength of plaque enhancement. RESULTS: Sixteen patients were studied during the acute phase (<4 weeks from acute stroke), 5 patients in the subacute phase (4-12 weeks), and 8 patients in the chronic phase (>12 weeks) of the ischemic injury. In all of the acute phase patients, atherosclerotic plaque in the vessel supplying the stroke territory demonstrated strong enhancement. There was a trend of decreasing enhancement as the time of imaging relative to the ischemic event increased. CONCLUSIONS: Strong pathologic enhancement of intracranial atherosclerotic plaque was seen in all patients imaged within 4 weeks of ischemic stroke in the vessel supplying the stroke territory. The strength and presence of enhancement of the atherosclerotic plaque decreased with increasing time after the ischemic event. These findings suggest a relationship between enhancing intracranial atherosclerotic plaque and acute ischemic stroke.
Authors: Vitalii V Itskovich; Daniel D Samber; Venkatesh Mani; Juan Gilberto S Aguinaldo; John T Fallon; Cheuk Y Tang; Valentin Fuster; Zahi A Fayad Journal: Magn Reson Med Date: 2004-09 Impact factor: 4.668
Authors: Andreas Koops; Harald Ittrich; Susan Petri; Andrew Priest; Alexander Stork; Ute Lockemann; Gerhard Adam; Christoph Weber Journal: Eur Radiol Date: 2006-04-27 Impact factor: 5.315
Authors: C R Weiss; A E Arai; M N Bui; K O Agyeman; M A Waclawiw; R S Balaban; R O Cannon Journal: J Magn Reson Imaging Date: 2001-12 Impact factor: 4.813
Authors: C Yuan; L M Mitsumori; M S Ferguson; N L Polissar; D Echelard; G Ortiz; R Small; J W Davies; W S Kerwin; T S Hatsukami Journal: Circulation Date: 2001-10-23 Impact factor: 29.690
Authors: James H F Rudd; Kelly S Myers; Sameer Bansilal; Josef Machac; Mark Woodward; Valentin Fuster; Michael E Farkouh; Zahi A Fayad Journal: Circ Cardiovasc Imaging Date: 2009-01-26 Impact factor: 7.792
Authors: A G van der Kolk; J J M Zwanenburg; N P Denswil; A Vink; W G M Spliet; M J A P Daemen; F Visser; D W J Klomp; P R Luijten; J Hendrikse Journal: AJNR Am J Neuroradiol Date: 2014-12-04 Impact factor: 3.825
Authors: Matthew D Alexander; Adam de Havenon; Seong-Eun Kim; Dennis L Parker; Joseph S McNally Journal: Neuroradiology Date: 2019-01-24 Impact factor: 2.804
Authors: Petrice M Cogswell; Taylor L Davis; Megan K Strother; Carlos C Faraco; Allison O Scott; Lori C Jordan; Matthew R Fusco; Blaise deB Frederick; Jeroen Hendrikse; Manus J Donahue Journal: J Magn Reson Imaging Date: 2017-01-06 Impact factor: 4.813
Authors: D M Mandell; M Mossa-Basha; Y Qiao; C P Hess; F Hui; C Matouk; M H Johnson; M J A P Daemen; A Vossough; M Edjlali; D Saloner; S A Ansari; B A Wasserman; D J Mikulis Journal: AJNR Am J Neuroradiol Date: 2016-07-28 Impact factor: 3.825
Authors: J D Schaafsma; S Rawal; J M Coutinho; J Rasheedi; D J Mikulis; C Jaigobin; F L Silver; D M Mandell Journal: AJNR Am J Neuroradiol Date: 2019-09-05 Impact factor: 3.825
Authors: Adam de Havenon; Mahmud Mossa-Basha; Lubdha Shah; Seong-Eun Kim; Min Park; Dennis Parker; J Scott McNally Journal: Neuroradiology Date: 2017-09-23 Impact factor: 2.804
Authors: Matthew D Alexander; Chun Yuan; Aaron Rutman; David L Tirschwell; Gerald Palagallo; Dheeraj Gandhi; Laligam N Sekhar; Mahmud Mossa-Basha Journal: J Neurol Neurosurg Psychiatry Date: 2016-01-08 Impact factor: 10.154